Adgorif 40 Tablet 28’s is a medication used to treat colorectal carcinoma, a type of cancer characterized by uncontrolled growth of malignant cells in the colon or rectum.
The active ingredient in Adgorif 40 Tablet 28’s is Regorafenib, which is classified as a kinase inhibitor. It functions by blocking the activity of an enzyme known as tyrosine kinase, thereby halting the abnormal proliferation of cancer cells.
Patients taking Adgorif 40 Tablet 28’s may experience side effects including diarrhea, rash, fatigue, decreased appetite, nausea, weight loss, stomach pain, loss of appetite, hoarseness, and dizziness. These side effects typically do not necessitate medical intervention and tend to resolve on their own over time. It is important to take Adgorif 40 Tablet 28’s as prescribed by your healthcare provider.
Do not use Adgorif 40 Tablet 28’s if you have an allergy to it or any of its components. Prior to starting this medication, inform your doctor if you have a history of liver or kidney disease, gastrointestinal issues, hypertension, heart conditions, blood disorders, are planning any surgeries, or have any skin conditions. This medication is not advised for use in pregnant or breastfeeding women due to potential risks to the embryo or fetus.
